The health service used Derm AI to identify 20,000 cancers among 230,000 patients. This vision-based tool analyzes skin lesions to flag malignancies for clinical review. While the scale of the rollout is impressive, the app remains a screening aid rather than a final diagnostic. Practitioners should treat these results as triage indicators.